Results

Total Results: 3,120 records

Showing results for "drug".

181. ADHD Behavior Therapy References (pdf file)
     www.ahrq.gov/sites/default/files/wysiwyg/policymakers/chipra/factsheets/fullreports/chipra-89-adhd-behavior-references.pdf
     August 12, 2012 - Silver Spring, MD: Food and Drug Administration, Center for Drug Evaluation and Research; 2004. … Silver Spring, MD: Food and Drug Administration, Center for Drug Evaluation and Research; 2004. … Mortality associated with attention- deficit hyperactivity disorder (ADHD) drug treatment: a retrospective … Drug Saf; 2009;32(11):1089-1110 McCarthy S, Cranswick N, Potts L, Taylor E, Wong IC. … Drug Saf. 2009;32(11):1089-1110 McGoey KE, DuPaul GJ, Haley E, Shelton TL.

182. References (pdf file)
     www.ahrq.gov/sites/default/files/wysiwyg/policymakers/chipra/factsheets/fullreports/chipra-88-references.pdf
     August 12, 2012 - Silver Spring, MD: Food and Drug Administration, Center for Drug Evaluation and Research; 2004. … Silver Spring, MD: Food and Drug Administration, Center for Drug Evaluation and Research; 2004. … Mortality associated with attention- deficit hyperactivity disorder (ADHD) drug treatment: a retrospective … Drug Saf; 2009;32(11):1089-1110 McCarthy S, Cranswick N, Potts L, Taylor E, Wong IC. … Drug Saf. 2009;32(11):1089-1110 McGoey KE, DuPaul GJ, Haley E, Shelton TL.

183. Agency for Healthcare Research and Quality
     www.ahrq.gov/research/findings/studies/index.html?page=337
     January 01, 2024 - Pharmacoepidemiol Drug Saf 2017 Mar;26(3):310-19. doi: 10.1002/pds.4126. . … This paper comments on the variety of drug treatment options for patients with type 2 diabetes. … , Nelson SD , Hines L Information needs for making clinical recommendations about potential drug-drug … understand the information needs and work practices of specialists who search and synthesize potential drug-drug … Information needs for making clinical recommendations about potential drug-drug interactions: a synthesis

184. Tool 3I: Medication Fall Risk Score and Evaluation Tools | Agency for Healthcare Research and Quality
     www.ahrq.gov/patient-safety/settings/hospital/fall-prevention/toolkit/medication-risk-score.html
     January 01, 2013 - committee or pharmacy department for formulary drugs within the American Hospital Formulary Service drug … for renal function or disease state, overuse of medications, IV access Laboratory Therapeutic drug

185. Tool 5 (continued) | Agency for Healthcare Research and Quality
     www.ahrq.gov/patient-safety/settings/hospital/hai/red/toolkit/postdischarge-doc.html
     March 01, 2013 - Medicine list for appropriate dosing, drug-drug and drug-food interactions, and major side effects. … ___ No change needed in discharge plan as it relates to the drug therapy ___ Educated patient/caregiver … ___ No change needed in discharge plan as it relates to the drug therapy ___ Educated patient/caregiver … ___ No change needed in discharge plan as it relates to the drug therapy ___ Educated patient/caregiver

186. Postdiscalldoc (doc file)
     www.ahrq.gov/sites/default/files/publications/files/postdiscalldoc.docx
     February 06, 2013 - phone call: Review: Health history Medicine lists for consistency Medicine list for appropriate dosing, drug-drug … and drug-food interactions, and major side effects Contact sheet DE notes Discharge summary and AHCP … No change needed in discharge plan as it relates to the drug therapy Educated patient/caregiver on proper … No change needed in discharge plan as it relates to the drug therapy Educated patient/caregiver on proper … No change needed in discharge plan as it relates to the drug therapy Educated patient/caregiver on proper

187. Postdiscalldoc (doc file)
     www.ahrq.gov/sites/default/files/wysiwyg/professionals/systems/hospital/red/toolkit/postdiscalldoc.docx
     February 06, 2013 - phone call: Review: Health history Medicine lists for consistency Medicine list for appropriate dosing, drug-drug … and drug-food interactions, and major side effects Contact sheet DE notes Discharge summary and AHCP … No change needed in discharge plan as it relates to the drug therapy Educated patient/caregiver on proper … No change needed in discharge plan as it relates to the drug therapy Educated patient/caregiver on proper … No change needed in discharge plan as it relates to the drug therapy Educated patient/caregiver on proper

188. Postdiscalldoc (doc file)
     www.ahrq.gov/sites/default/files/wysiwyg/patient-safety/settings/hospitals/red-toolkit/postdiscalldoc.docx
     February 06, 2013 - phone call: Review: Health history Medicine lists for consistency Medicine list for appropriate dosing, drug-drug … and drug-food interactions, and major side effects Contact sheet DE notes Discharge summary and AHCP … No change needed in discharge plan as it relates to the drug therapy Educated patient/caregiver on proper … No change needed in discharge plan as it relates to the drug therapy Educated patient/caregiver on proper … No change needed in discharge plan as it relates to the drug therapy Educated patient/caregiver on proper

189. Agency for Healthcare Research and Quality
     www.ahrq.gov/research/findings/studies/index.html?page=349
     January 01, 2024 - This article focuses on recommendations from the Adverse Drug Events (ADE) Action Plan to help guide … Keywords: Prevention, Opioids, Patient Safety, Ambulatory Care and Surgery, Adverse Drug Events (ADE … Personnel, Health Services Research (HSR), Outcomes Cho I , Lee JH , Choi J National rules for drug-drug … This study investigated the potential impact of Korean national drug-drug interactions (DDI) rules in … National rules for drug-drug interactions: are they appropriate for tertiary hospitals?

190. Final Progress Report: Improving Patient Safety by Reducing Medication Errors (pdf file)
     www.ahrq.gov/sites/default/files/2024-03/strom2-report.pdf
     January 01, 2024 - use, and drug level at admission. … name, American Hospital Formulary Service (AHFS) drug class, national drug code (NDC), drug dose, … Each of the drug cohorts was analyzed separately. … Pharmacoepidemiology and Drug Safety 2007; 16:S46-S47. … Pharmacoepidemiology and Drug Safety 2006; 15:S52-S53.

191. Identification, Classification, and Frequency of Medical Errors in Outpatient Diabetes Care (pdf file)
     www.ahrq.gov/sites/default/files/wysiwyg/professionals/quality-patient-safety/patient-safety-resources/resources/advances-in-patient-safety/vol1/OConnor.pdf
     November 29, 2004 - Inappropriate or risky drug prescribing occurred in 9.9 percent of the 5,729 patients. … Among the categories of drug-related medical errors are those related to drug-drug interactions, use … dl With drug intensification 159 3.8% LDL ≥ 130 mg/dl No drug intensification 536 12.9% Triglycerides … +Drug-fill date more than 4 weeks after test date. … +Type 1 lipid error is inadequate drug treatment when LDL ranges 100-129 mg/dl.

192. 5 Tk1 T5-Sample Policy Letter Final (pdf file)
     www.ahrq.gov/sites/default/files/wysiwyg/nhguide/5_TK1_T5-Sample_Policy_Letter_final.pdf
     October 01, 2016 - The adverse consequences of unnecessary antibiotic use include adverse drug reactions or interactions … , the development of Clostridium difficile infections, the emergence of multi-drug resistant organisms … overuse of newer, broad-spectrum antibiotics when either no antibiotic or an older narrow-spectrum drug

193. 5 Tk1 T5-Sample Policy Letter Final (doc file)
     www.ahrq.gov/sites/default/files/wysiwyg/nhguide/5_TK1_T5-Sample_Policy_Letter_final.docx
     October 01, 2016 - The adverse consequences of unnecessary antibiotic use include adverse drug reactions or interactions … , the development of Clostridium difficile infections, the emergence of multi-drug resistant organisms … and overuse of newer, broad-spectrum antibiotics when either no antibiotic or an older narrowspectrum drug

194. Agency for Healthcare Research and Quality
     www.ahrq.gov/research/findings/studies/index.html?page=332
     January 01, 2024 - , Surgery, Hospital Readmissions, Mortality Hanlon JT , Perera S , Newman AB Potential drug-drug … and drug-disease interactions in well-functioning community-dwelling older adults. … The objective of this study was to describe the prevalence of potential drug-drug and drug-disease interactions … Potential drug-drug and drug-disease interactions in well-functioning community-dwelling older adults … Keywords: Adverse Drug Events (ADE), Elderly, Medication, Patient Safety Poghosyan L , Liu

195. Agency for Healthcare Research and Quality
     www.ahrq.gov/research/findings/studies/index.html?page=327
     January 01, 2024 - , Salomon MM , Galanter WL Cognitive tests predict real-world errors: the relationship between drug … name memory and perception and real-world drug name confusion error rates. … found that across two distinct pharmacy chains, there is a strong and significant association between drug … E-prescribing and adverse drug events: an observational study of the Medicare part D population with … A history of nonsteroidal anti-inflammatory drug allergy was identified as a risk factor for patients

196. Appendix, MATCH Resources for Patients | Agency for Healthcare Research and Quality
     www.ahrq.gov/patient-safety/settings/hospital/match/appendix/app-12.html
     July 01, 2022 - Food and Drug Administration The U.S. … Food and Drug Administration (FDA) is responsible for protecting the public's health by assuring the … This Web site also offers a drug information resource, MedMaster, which is a searchable database to learn

197. Appendix, MATCH Resources for Patients | Agency for Healthcare Research and Quality
     www.ahrq.gov/es/patient-safety/settings/hospital/match/appendix/app-12.html
     July 01, 2022 - Food and Drug Administration The U.S. … Food and Drug Administration (FDA) is responsible for protecting the public's health by assuring the … This Web site also offers a drug information resource, MedMaster, which is a searchable database to learn

198. HIV and AIDS | Agency for Healthcare Research and Quality
     www.ahrq.gov/research/findings/nhqrdr/chartbooks/effectivetreatment/hiv.html
     April 01, 2018 - Sharing of drug needles with an infected person. … Injection drug users. Homeless people. … Injection drug use (males), 3.6% (1,590). Injection drug use (females), 2.4% (1,045). … Male-to-male sexual contact and injection drug use, 2.8% (1,217). … Injection drug users obtain and spread HIV by: Sharing drug preparation or injecting equipment with

199. Drugs to Treat COVID | Agency for Healthcare Research and Quality
     www.ahrq.gov/data/infographics/drugs-covid.html
     August 01, 2021 - Drugs to Treat COVID   Drugs to Treat COVID (PDF, 459 KB) Source:  AHRQ, Medical Expenditure Panel Survey Research Findings #49, Pre-COVID Retail Use and Expenditures for Drugs That Were Subsequently Used to Treat COVID .

200. Tk2 T4 Common Suspected Infections Tools To Improve Communication And Decisionmaking (doc file)
     www.ahrq.gov/sites/default/files/wysiwyg/nhguide/TK2_T4_Common_Suspected_Infections_Tools_To_Improve_Communication_and_Decisionmaking.docx
     October 01, 2016 - Antibiotics SAY: To return to the big picture, not only are resistant strains proliferating, but new drug … Slide 6 Developing a New Drug Is Expensive SAY: There are many reasons for the lack of development … As this slide shows, using constant dollars as its reference point, the cost of bringing a new drug to … In contrast, a new drug for a chronic problem such as high cholesterol or congestive heart failure will … Yet if antibiotic resistance does develop, it will limit the effective lifespan of the drug.